Clinical characteristics of ALS subsets;Quels sont les critères cliniques de la sclérose latérale amyotrophique en fonction des formes cliniques?

Revue Neurologique

Volumn 162, Issue HS2, 2006, Pages

  Pradat, P F ^a   Bruneteau, G ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

ALS; Primary lateral sclerosis; Progressive bulbar palsy; Progressive muscular atrophy

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; DISEASE ASSOCIATION; HUMAN; ONSET AGE; PROGNOSIS; CLASSIFICATION; CONSENSUS DEVELOPMENT;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS;

EID: 33750032901     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. ABE K, AOKI M, IKEDA M, WATANABE M, HIRAI S,ITOYAMA Y. (1996). Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci, 136: 108-116.
2. AL SHAIKH B, KINNEAR W, HIGENBOTTAM TW, SMITH HS, SHNEERSON JM, WILKINSON I. (1986). Motor neurone disease presenting as respiratory failure. Br Med J (Clin Res Ed), 292: 1325-1326.
3. ANAES. (2000). Guide d'analyse de la littérature et gradation des recommandations. http://www.has-sante.fr/anaes/Publications.nsf/w Edition/RA_LILF-4NAHYY.
4. ANDERSEN PM. (2000). Genetic factors in the early diagnosis of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord, 1 Suppl 1: S31-S42.
5. ANDERSEN PM, FORSGREN L, BINZER M, NILSSON P, ALA-HURULA V, KERANEN ML, BERGMARK L et al. (1996). Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain, 119: 1153-1172.
6. ARGYRIOU AA, POLYCHRONOPOULOS P, PAPAPETROPOULOS S, ELLUL J, ANDRIOPOULOS I, KATSOULAS G, SALAKOU S et al. (2005). Clinical and epidemiological features of motor neuron disease in southwestern Greece. Acta Neurol Scand, 111: 108-113.
7. BOUCHE P, LE FORESTIER N. (1999). Sclérose latérale amyotrophique (I). Aspects cliniques. Encycl Méd Chir (Elsevier, Paris), Neurologie, 17-078-A-10, 1999, 10 p.
8. BROOKS BR. (1999). Diagnostic dilemmas in amyotrophic lateral sclerosis. J Neurol Sci, 165 Suppl 1: S1-S9.
9. BROOKS BR, MILLER RG, SWASH M,MUNSAT TL. (2000). El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord, 1: 293-299.
10. CAMU W, KHORIS J, MOULARD B, SALACHAS F, BRIOLOTTI V, ROULEAU GA, MEININGER V. (1999). Genetics of familial ALS and consequences for diagnosis. French ALS Research Group. J Neurol Sci, 165 Suppl 1: S21-S26.
11. DE CARVALHO M, MATIAS T, COELHO F, EVANGELISTA T, PINTO A, LUIS ML. (1996). Motor neuron disease presenting with respiratory failure. J Neurol Sci, 139 Suppl: 117-122.
12. DUPRÉ N, PRADAT PF, BOUCHARD GA, MEININGER V. (2005). La sclérose latérale amyotrophique: une maladie d'origine génétique et environnementale. La Lettre du Neurologue, 9: 139-142.
13. EYMARD-PIERRE E, LESCA G, DOLLET S, SANTORELLI FM, DI CAPUA M, BERTINI E, BOESPFLUG-TANGUY O. (2002). Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet, 71: 518-527.
14. FROMM GB, WISDOM PJ, BLOCK AJ. (1977). Amyotrophic lateral sclerosis presenting with respiratory failure. Diaphragmatic paralysis and dependence on mechanical ventilation in two patients. Chest, 71: 612-614.
15. GALASKO D, SALMON DP, CRAIG UK, THAL LJ, SCHELLENBERG G, WIEDERHOLT W. (2002). Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology, 58: 90-97.
16. GUBBAY SS, KAHANA E, ZILBER N, COOPER G, PINTOV S, LEIBOWITZ Y. (1985). Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol, 232: 295-300.
17. HOWARD RS, WILES CM, LOH L. (1989). Respiratory complications and their management in motor neuron disease. Brain, 112 (Pt 5): 1155-1170.
18. JAFARI-SCHLUEP HF, KHORIS J, MAYEUX-PORTAS V, HAND C, ROULEAU G, CAMU W. (2004). Les anomalies du gène superoxyde dismutase 1 dans le sclérose latérale amyotrophique familiale: corrélations phénotype/génotype et implications pratiques. L'expérience française et revue de la littérature. Rev Neurol (Paris), 160: 44-50.
19. KATZ JS, WOLFE GI, ANDERSSON PB, SAPERSTEIN DS, ELLIOTT JL, NATIONS SP, BRYAN WW,BAROHN RJ. (1999). Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology, 53: 1071-1076.
20. KAWATA A, KATO S, HAYASHI H, HIRAI S. (1997). Prominent sensory and autonomic disturbances in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene. J Neurol Sci, 153: 82-85.
21. KHORIS J, MOULARD B, BRIOLOTTI V, HAYER M, DURIEUX A, CLAVELOU P, MALAFOSSE A et al. (2000). Coexistence of dominant and recessive familial amyotrophic lateral sclerosis with the D90A Cu,Zn superoxide dismutase mutation within the same country. Eur J Neurol, 7: 207-211.
22. KUZUHARA S, KOKUBO Y, SASAKI R, NARITA Y, YABANA T, HASEGAWA M, IWATSUBO T. (2001). Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii Peninsula of Japan: clinical and neuropathological study and tau analysis. Ann Neurol, 49: 501-511.
23. LE FORESTIER N, MAISONOBE T, SPELLE L, LESORT A, SALACHAS F, LACOMBLEZ L, SAMSON Y et al. (2001). Primary lateral sclerosis: further clarification. J Neurol Sci, 185: 95-100.
24. LEIGH PN, ABRAHAMS S, AL CHALABI A, AMPONG MA, GOLDSTEIN LH, JOHNSON J, LYALL R et al. (2003). The management of motor neurone disease. J Neurol Neurosurg Psychiatry, 74 Suppl 4: iv32-iv47.
25. LESCA G, EYMARD-PIERRE E, SANTORELLI FM, CUSMAI R, DI CAPUA M, VALENTE EM, ATTIA-SOBOL J et al. (2003). Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology, 60: 674-682.
26. LI TM, ALBERMAN E, SWASH M. (1990). Clinical features and associations of 560 cases of motor neuron disease. J Neurol Neurosurg Psychiatry, 53: 1043-1045.
27. MAGNUS T, BECK M, GIESS R, PULS I, NAUMANN M, TOYKA KV. (2002). Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve, 25: 709-714.
28. MEYRIGNAC C, POIRIER J, DEGOS JD. (1985). Amyotrophic lateral sclerosis presenting with respiratory insufficiency as the primary complaint. Clinicopathological study of a case. Eur Neurol, 24: 115-120.
29. MITSUMOTO H, CHAD DA, PIORO EP. (1998a). Clinical features: signs and symptoms. In Amyotrophic Lateral Sclerosis, H. Mitsumoto, D.A. Chad, and E. P. Pioro, eds. (Philadelphie: FA Davis Company), pp. 47-64.
30. MITSUMOTO H, CHAD DA, PIORO EP. (1998b). Familial ALS. In Amyotrophic Lateral Sclerosis, H. Mitsumoto, D.A. Chad, and E.P. Pioro, eds. (Philadelphie: FA Davis Company), pp. 164-176.
31. MITSUMOTO H, CHAD DA, PIORO EP. (1998c). History, terminology and classification of ALS. In Amyotrophic lateral sclerosis, H. Mitsumoto, D. A. Chad, and E. P. Pioro, eds. (Philadelphia: FA Davis Company), pp. 3-17.
32. MORRIS HR, AL SARRAJ S, SCHWAB C, GWINN-HARDY K, PEREZ-TUR J, WOOD NW, HARDY J et al. (2001). A clinical and pathological study of motor neurone disease on Guam. Brain, 124: 2215-2222.
33. MOULARD B, CAMU W, MALAFOSSE A, BILLIARD M, BALDY-MOULINIER M. (1997). Étude clinique des formes familiales de sclérose latérale amyotrophique. Revue de la littérature. Rev Neurol (Paris), 153: 314-324.
34. MULDER DW, KURLAND LT, OFFORD KP, BEARD CM. (1986). Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology, 36: 511-517.
35. NIGHTINGALE S, BATES D, BATEMAN DE, HUDGSON P, ELLIS DA, GIBSON GJ. (1982). Enigmatic dyspnoea: an unusual presentation of motor-neurone disease. Lancet, 1: 933-935.
36. MORRIS F, SHEPHERD R, DENYS E, U K, MUKAI E, ELIAS L, HOLDEN D, MORRIS H. (1993). Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci, 118: 48-55.
37. ROSATI G, PINNA L, GRANIERI E, AIELLO I, TOLA R, AGNETTI V, PIRISI A et al. (1977). Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand, 55: 231-244.
38. ROSEN AD. (1978). Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol, 35: 638-642.
39. SHANKAR SK, YANAGIHARA R, GARRUTO RM, GRUNDKE-IQBAL I, KOSIK KS, GAJDUSEK DC. (1989). Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Ann Neurol, 25: 146-151.
40. SHIMIZU T, KAWATA A, KATO S, HAYASHI M, TAKAMOTO K, HAYASHI H, HIRAI S et al. (2000). Autonomic failure in ALS with a novel SOD1 gene mutation. Neurology, 54: 1534-1537.
41. SIDDIQUE T, FIGLEWICZ DA, PERICAK-VANCE MA, HAINES JL, ROULEAU G, JEFFERS AJ, SAPP P et al. (1991). Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med, 324: 1381-1384.
42. SWASH M. (1995). The diagnosis of amyotrophic lateral sclerosis. A discussion. Adv Neurol, 68: 157-160.
43. TESTA D, LOVATI R, FERRARINI M, SALMOIRAGHI F, FILIPPINI G. (2004). Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord, 5: 208-212.
44. TOMIK B, NICOTRA A, ELLIS CM, MURPHY C, RABE-HESKETH S, PARTON M, SHAW CE et al. (2000). Phenotypic differences between African and white patients with motor neuron disease: a case-control study. J Neurol Neurosurg Psychiatry, 69: 251-253.
45. TRAYNOR BJ, CODD MB, CORR B, FORDE C, FROST E, HARDIMAN OM. (2000). Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Arch Neurol, 57: 1171-1176.
46. TYSNES OB, VOLLSET SE, AARLI JA. (1991). Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand, 83: 280-285.
47. VERMA A, BRADLEY WG. (2001). Atypical motor neuron disease and related motor syndromes. Semin Neurol, 21: 177-187.
48. WARING SC, ESTEBAN-SANTILLAN C, Reed DM, CRAIG UK, LABARTHE DR, PETERSEN RC, KURLAND LT. (2004). Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology, 23: 192-200.
49. WILLIAMS DB, FLOATE DA, LEICESTER J. (1988). Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci, 86: 215-230.